Thermo Fisher Plans Viral Vector Development and Manufacturing Facility
Published 5-19-2020
Thermo Fisher Scientific is planning to build a $180 million viral vector development and manufacturing facility in Plainville, Mass.
Published 5-19-2020
Thermo Fisher Scientific is planning to build a $180 million viral vector development and manufacturing facility in Plainville, Mass.
Published 5-18-2020
Biogen completed construction in late spring of 2020 on a leading-edge biologics manufacturing center in Luterbach, Switzerland.
Published 5-14-2020
Global pharmaceutical firm XBiotech is planning to construct a 30,000-sf R&D laboratory in Austin, Texas.
Published 5-11-2020
Hixson is offering a free webinar at 2:00 PM EDT on May 14, 2020.
Published 5-6-2020
E4H Architecture presented a webinar on modular facilities for accelerating vaccine development on May 8, 2020.
Published 5-6-2020
Exicure, a clinical-stage biotechnology firm, has leased 30,000 sf in The Labs in Chicago.
Published 5-5-2020
The Vaccines Manufacturing Innovation Centre (VIMC) is being constructed on an accelerated schedule in Oxford in the United Kingdom.
Published 4-24-2020
Novo Nordisk completed a $5.1 million tenant renovation and expansion project in March of 2020 in Fremont, Calif.
Published 4-20-2020
The International Society for Pharmaceutical Engineering has announced the 2020 Facility of the Year Awards category winners. The awards include:
Published 4-15-2020
VACUUBRAND is offering continuing education courses approved by the American Institute of Architects and Green Business Certification Inc.